Cases 11 - 20 of 117
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma, Inc. v. Aurobindo Pharma Ltd.
as 23-2089
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities, Ltd. et al
as 1:2022cv01611
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Defendant:
Eugia Pharma Specialities, Ltd., Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01467
Plaintiff:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01391
Plaintiff:
Alcon Inc. and Alcon Laboratories, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc.
as 23-1171
Plaintiff / Appellee:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A.
Defendant / Appellant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al
as 1:2022cv01270
Plaintiff:
Bial - Portela & CA S.A., Bial - Holding, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00971
Plaintiff:
Covis Pharma GmbH, AMAG Pharma USA, Inc. and AMAG Pharmaceuticals, Inc.
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 1:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 3:2022cv03610
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
